Search
Dr. Anil Saxena

Dr. Anil Saxena

Director

43 Years of Experience

Interventional Cardiologist

MBBS, MD, DNB

Reg. No.:6612 Delhi Medical Council, 2000

Fortis Escorts Heart Institute, Okhla, New Delhi

English

Consultation Fee ₹ 1500

Book an Appointment Contact with Doctor

Confirm Your Consultation With Dr. Anil Saxena

Expert Help When You Need It – Plan in 60 Minutes

About Dr. Anil Saxena

  • Dr. Anil Saxena is an internationally recognized Interventional Cardiologist with over 43 years of experience.
  • He is an expert in cardiac arrhythmias and electrophysiology.
  • Dr. Saxena has extensive experience in implanting ICDs and biventricular pacemakers and is considered one of the pioneers in this field in India.
  • He holds an MBBS degree from 1992 and an MD degree from 1985, both from Kanpur University, as well as a DNB degree from the National Board of Examinations in 1999.
  • With over 30 years of experience, he has successfully performed electrophysiological studies and radiofrequency catheter ablation for various complex arrhythmias, having completed thousands of procedures.
  • Dr. Saxena has been instrumental in setting up the Department of Cardiac Electrophysiology at Fortis Escorts Heart Institute since joining in 1989.

Confirm Your Consultation With Dr. Anil Saxena

Expert Help When You Need It – Plan in 60 Minutes

Education

  • MBBS, Kanpur University, 1982
  • MD (Internal Medicine), Kanpur University, 1985
  • DNB (Cardiology), National Board Of Examination, 1993

Training & Certificates

  • Training (Cardiac electrophysiology), St Luke Hospital, Wisconsin, USA

OPD Schedule Of Dr. Anil Saxena

Book Appointment
  • Shri G L Raturi Oration Award By IMA - 2002
  • Dr. O P Goel Memorial Oration Award By IMA - 2004
  • Prof. H.S. Mittal Memorial Oration Award by the Indian Medical Association
  • Dr. O P Goel Memorial Oration Award by the Indian Medical Association, Meerut
  • Reply to letters vide manuscript ID IPEJ-D-20-00072 and IPEJ-D-20-00073 regarding our paper “Cardiovascular risks of hydroxychloroquine in treatment and prevention of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society?, 2020
  • European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population, 2020
  • European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: Use the right tool for the right outcome, in the right population, 2020
  • Utility of 3D mapping in Electrophysiology-Less Time with Greater Success in Difficult Accessory Pathway Ablation, 2023
  • The Power and Promise of Angiotensin Receptor Neprilysin Inhibitor (ARNI) in Heart Failure Management: National Consensus Statement The Power and Promise of Angiotensin Receptor Neprilysin Inhibitor, 2023
  • 3D Mapping and Ablation of Left-Sided Atypical Atrial Flutter, 2022
  • Identifying high-risk patients post myocardial infarction with reduced left ventricular function using loop recorders INSPIRE-ELR clinical study, 2022
  • The apparent change in atrial activation sequence of atrioventricular reentrant tachycardia during application of radiofrequency energy for ablation of a left lateral accessory pathway, 2006
  • QRS Width as a Predictor of Occurrence of Clinical Ventricular Tachycardia in Patients with Internal Cardioverter Defibrillator, 2005
  • Implantation Characteristics of Left Ventricular Pacing Leads in Patients undergoing Cardiac Resynchronization Therapy, 2004
  • Morphology of Monomorphic Ventricular Tachycardias Induced during Programmed Ventricular Stimulation, 2004
  • Cardiovascular risks of hydroxychloroquine in treatment and prevention of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society, 2020
  • Evaluation, Management, and Outcomes of Patients Poorly Responsive to Cardiac Resynchronization Device Therapy, 2019
  • 2017 Consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation, 2017
  • Do the Application and Effect of Cardiac Resynchronization Therapy Differ between the USA and Asia? Insights from the International ADVANCE CRT Registry, 2016
  • The Indian Consensus Guidance on stroke prevention in atrial fibrillation: An emphasis on practical use of nonvitamin K oral anticoagulants, 2015
  • Narrow QRS incessant tachycardia in a patient with recent myocardial infarction: What is the mechanism, 2008
  • Slow pathway ablation in a patient with common atrioventricular nodal reentrant tachycardia and prolonged baseline PR interval, 1999
  • Delhi Medical Council

Best Cardiology Doctors in India

View All
View All
Enquiry Now